Pillstats
Rx only · Capsule · Oral

Tasimelteon

Brands: Hetlioz · Tasimelteon

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05CH03
RxCUI (US)1490468
US makers3 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$116.11$232.23$348.34$464.45Dec 2025Apr 2026Jul 2026
$310.542
Latest avg · Jul 22, 2026
-21%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2274546819082025 Q12025 Q22025 Q32025 Q42026 Q1
749
Rx · 2026 Q1
23K
Units dispensed
+68%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Apotex Corp.unknown2SUPPLYING
Vanda Pharmaceuticals Inc.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.